Curis | CRIS - الأصول





الأصول تغيير تاريخ
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
CSL USD 37.9B 1.5B 2025-12
Curis USD 29.69M 9.72M 2026-03
Eli Lilly USD 142.28B 25.71B 2026-06
Exelixis USD 2.49B 99.36M 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Takeda JPY 15.66T 210.16B 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Verastem USD 227.81M 18.63M 2026-03